Patents by Inventor Christopher Kuyler Doyle

Christopher Kuyler Doyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9814768
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: November 14, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • Publication number: 20170173136
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 22, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher Kuyler DOYLE
  • Patent number: 9605033
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: March 28, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • Publication number: 20150338406
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Application
    Filed: June 3, 2015
    Publication date: November 26, 2015
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Jere W. McBRIDE, Christopher Kuyler DOYLE
  • Publication number: 20100330091
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Application
    Filed: August 7, 2007
    Publication date: December 30, 2010
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • Publication number: 20100183654
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Application
    Filed: June 15, 2006
    Publication date: July 22, 2010
    Applicant: Research Development Foundation
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • Patent number: 7722880
    Abstract: The present invention is directed to the cloning, sequencing, expression, and characterization of an immunoreactive ferric binding protein (Fbp) (38-kDa) protein of Ehrlichia canis encoded by a polynucleotide therefor. In particular embodiments, the protein is employed in an immunogenic composition, such as a vaccine. Methods to induce an immune reaction in an individual with compositions of the invention are provided.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: May 25, 2010
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, David H. Walker, Christopher Kuyler Doyle